Coherus Oncology, Inc.
CHRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001512762
No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Coherus Oncology, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 112 | 2 | 114 | +4 |
| Shares | 55.3M | 52.3K | 51.6M | −3.64M (−6.6%) |
| Value | $40.4M | $38.6K | $84.6M | +$44.3M (+109.7%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Coherus Oncology, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Colony Group, LLC | 42,986 | $135.3K | 0.00% |
| MetLife Investment Management | 63,678 | $104.4K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 63,156 | $103.6K | 0.00% |
| Two Sigma Investments, LP | 35,712 | $58.6K | 0.00% |
| Manufacturers Life Insurance Company, The | 33,469 | $54.9K | 0.00% |
| Quadrature Capital Ltd | 18,172 | $29.7K | 0.00% |
| Voya Investment Management LLC | 16,971 | $27.8K | 0.00% |
| Quarry LP | 15,572 | $25.5K | 0.01% |
| Two Sigma Securities, LLC | 14,706 | $24.1K | 0.00% |
| Riverview Capital Advisers, LLC | 12,946 | $21.2K | 0.01% |
| Two Sigma Advisers, LP | 12,500 | $20.5K | 0.00% |
| SG Americas Securities, LLC | 11,944 | $20.0K | 0.00% |
| CIBC Bancorp USA Inc. | 11,306 | $18.5K | 0.00% |
| Cubist Systematic Strategies, LLC | 10,789 | $17.7K | 0.00% |
| Russell Investments Group, Ltd. | 8,784 | $14.4K | 0.00% |
| SRS Capital Advisors, Inc. | 7,311 | $12.0K | 0.00% |
| Optiver Holding B.V. | 1,844 | $3.02K | 0.00% |
| Steigerwald, Gordon & Koch Inc. | 1,000 | $1.64K | 0.00% |
| Federated Hermes, Inc. | 479 | $786 | 0.00% |
| Rockefeller Capital Management L.P. | 324 | $531 | 0.00% |
| Allworth Financial LP | 10 | $17 | 0.00% |
Sold out (17)
Institutions that held Coherus Oncology, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Millennium Management LLC | 1,382,153 | $1.01M |
| Rubric Capital Management LP | 867,800 | $634.6K |
| Tejara Capital Ltd | 698,770 | $511.0K |
| Graham Capital Management, L.P. | 231,255 | $169.1K |
| Stonepine Capital Management, LLC | 62,700 | $45.9K |
| HRT Financial LP | 48,778 | $35.0K |
| Squarepoint Ops LLC | 41,058 | $30.0K |
| State Board of Administration of Florida Retirement System | 29,583 | $21.6K |
| Virtu Financial LLC | 24,865 | $18.0K |
| Pallas Capital Advisors LLC | 13,696 | $10.0K |
| Shay Capital LLC | 10,296 | $7.53K |
| Commerce Bank | 10,000 | $7.31K |
| Shell Asset Management Co | 9,137 | $7.00K |
| Raymond James Financial Inc | 3,102 | $2.27K |
| CBIZ Investment Advisory Services, LLC | 156 | $114 |
| Larson Financial Group LLC | 79 | $58 |
| Clark Wealth Partners | 23 | $17 |
Not filed for Q3 2025 yet (2)
Institutions that held Coherus Oncology, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Wealth Group, Ltd. | 39,195 | $29.0K |
| CIBC World Markets Corp | 13,068 | $9.56K |